(Q37703190)

22 August 2017

1 reference

title

Pharmacotherapy options for locally advanced and advanced cervical cancer (English)

1 reference

22 August 2017

0 references

cervix uterine cancer

1 reference

inferred from title

author name string

Alfonso Dueñas-González

1

1 reference

22 August 2017

Lucely Cetina

2

1 reference

22 August 2017

Jaime Coronel

3

1 reference

22 August 2017

Déborah Martínez-Baños

4

1 reference

22 August 2017

publication date

1 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

70

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

403-432

1 reference

Stage IA2 squamous carcinoma of the cervix: difficult diagnosis and therapeutic dilemma.

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: a randomized Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Radiation sensitivity of human squamous cell carcinoma cells in vitro is modulated by all-trans and 13-cis-retinoic acid in combination with interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Carboplatin and paclitaxel in metastatic or recurrent cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Lack in efficacy for imatinib mesylate as second-line treatment of recurrent or metastatic cervical cancer expressing platelet-derived growth factor receptor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Role of mitomycin C in the development of late bowel toxicity foloowing chemoradiation for locally advanced carcinoma of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11534370-000000000-00000

Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix

21 January 2018

1 reference

12 December 2020

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

1 reference

12 December 2020

High-dose density chemotherapy followed by simple trachelectomy: full-term pregnancy.

1 reference

12 December 2020

Cetuximab, topotecan and cisplatin for the treatment of advanced cervical cancer: A phase II GINECO trial

1 reference

12 December 2020

13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial

1 reference

12 December 2020

Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvan

1 reference

12 December 2020

Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma

1 reference

12 December 2020

Neoadjuvant chemotherapy before surgery in cervical cancer.

1 reference

12 December 2020

The clinical outcome of patients with stage Ia1 and Ia2 squamous cell carcinoma of the uterine cervix: a Cooperation Task Force (CTF) study.

1 reference

12 December 2020

Radiation therapy with or without weekly cisplatin for bulky stage 1B cervical carcinoma: follow-up of a Gynecologic Oncology Group trial

1 reference

12 December 2020

Effect of doxorubicin on cell survival and micronuclei formation in HeLa cells exposed to different doses of gamma-radiation

1 reference

12 December 2020

Interferon-alpha 2a, 13-cis-retinoic acid and radiotherapy for locally advanced carcinoma of the cervix: a pilot study

1 reference

12 December 2020

Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration

1 reference

12 December 2020

Prognostic significance of pathological response after neoadjuvant chemotherapy or chemoradiation for locally advanced cervical carcinoma

1 reference

12 December 2020

Gemcitabine-mediated radiosensitization.

1 reference

12 December 2020

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

1 reference

12 December 2020

Concurrent 5-fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer

1 reference

12 December 2020

Assessment of renal function in the early stages of nephrotoxicity induced by iodinated contrast media

1 reference

12 December 2020

Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

A phase I study of gemcitabine followed by cisplatin concurrent with whole pelvic radiation therapy in locally advanced cervical cancer: a Gynecologic Oncology Group study

1 reference

12 December 2020

Correlation between thymidine phosphorylase expression and invasion phenotype in cervical carcinoma cells

1 reference

12 December 2020

Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study

1 reference

12 December 2020

DNA topoisomerase I-targeting drugs as radiation sensitizers.

1 reference

12 December 2020

Chemoradiation with gemcitabine for cervical cancer in patients with renal failure

1 reference

12 December 2020

Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer

1 reference

12 December 2020

Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer

1 reference

12 December 2020

New cisplatin analogues in development. A review

1 reference

12 December 2020

A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer

1 reference

12 December 2020

Concurrent carboplatin and paclitaxel with pelvic radiation therapy in the primary treatment of cervical cancer

1 reference

12 December 2020

Evaluation of pelvic exenteration for advanced cancer of the cervix

1 reference

12 December 2020

Elevated topoisomerase I activity in cervical cancer as a target for chemoradiation therapy

1 reference

12 December 2020

Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

12 December 2020

Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer

1 reference

12 December 2020

Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.

1 reference

12 December 2020

Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group

1 reference

12 December 2020

Mechanism of vinorelbine-induced radiosensitization of human small cell lung cancer cells

1 reference

12 December 2020

Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study

1 reference

12 December 2020

Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose

1 reference

12 December 2020

Estimating the world cancer burden: Globocan 2000.

1 reference

12 December 2020

Phase I study of daily cisplatin and concurrent radiotherapy in patients with cervical carcinoma

1 reference

12 December 2020

Combined treatment of 4'-epi-doxorubicin and radiation on hamster lung cells

1 reference

12 December 2020

Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review.

1 reference

12 December 2020

Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer

1 reference

12 December 2020

Synchronous 5-fluorouracil, mitomycin-C and radiation therapy in the treatment of locally advanced carcinoma of the cervix

1 reference

12 December 2020

Single agent epirubicin in squamous cell cervical cancer. A phase II trial

1 reference

12 December 2020

Carboplatin versus cisplatin in solid tumors: an analysis of the literature

1 reference

12 December 2020

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

1 reference

12 December 2020

A phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma.

1 reference

12 December 2020

In vitro phase II comparison of the cytotoxicity of a novel platinum analog, nedaplatin (254-S), with that of cisplatin and carboplatin against fresh, human cervical cancers

1 reference

12 December 2020

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group stud

1 reference

12 December 2020

Phase II study of radiation therapy combined with weekly nedaplatin in locally advanced uterine cervical carcinoma (LAUCC): Kitasato Gynecologic Radiation Oncology Group (KGROG 0501)--initial analysis.

1 reference

12 December 2020

A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer

1 reference

12 December 2020

Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer

1 reference

12 December 2020

Compliance with and acute hematologic toxic effects of chemoradiation in indigent women with cervical cancer

1 reference

12 December 2020

Phase III randomized pilot study comparing interferon alpha-2b in combination with radiation therapy versus radiation therapy alone in patients with stage III-B carcinoma of the cervix

1 reference

12 December 2020

Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results

1 reference

12 December 2020

Carboplatin as a potentiator of radiation therapy

1 reference

12 December 2020

Laparoscopic sentinel node procedure for cervical cancer: impact of neoadjuvant chemoradiotherapy

1 reference

12 December 2020

Topotecan concomitant with primary brachytherapy radiation in patients with cervical carcinoma: a phase I trial

1 reference

12 December 2020

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

1 reference

12 December 2020

A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer

1 reference

12 December 2020

Radiation reduces carboplatin sensitivity and enhances nedaplatin sensitivity in cervical squamous cell carcinoma in vitro.

1 reference

12 December 2020

Chemoradiation and adjuvant chemotherapy in cervical cancer

1 reference

12 December 2020

Interim results of a randomized trial of mitomycin C as an adjunct to radical radiotherapy in the treatment of locally advanced squamous-cell carcinoma of the cervix

1 reference

12 December 2020

Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis.

1 reference

12 December 2020

Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results

1 reference

12 December 2020

Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer

1 reference

12 December 2020

A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer

1 reference

12 December 2020

Randomized trial of cisplatin and ifosfamide with or without bleomycin in squamous carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

Effects of urinary tract obstruction on renal function

1 reference

12 December 2020

Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature

1 reference

12 December 2020

Prognostic factors in advanced stage squamous cell cancer of the cervix

1 reference

12 December 2020

Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts

1 reference

12 December 2020

Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma

1 reference

12 December 2020

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial

1 reference

12 December 2020

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

12 December 2020

A phase I-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy in locally advanced cervical carcinoma

1 reference

12 December 2020

Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix

1 reference

12 December 2020

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation

1 reference

12 December 2020

Continuous infusion of carboplatin during conventional radiotherapy treatment in advanced squamous carcinoma of the cervix uteri IIB-IIIB (UICC). A phase I/II and pharmacokinetic study

1 reference

12 December 2020

Pregnancy after neoadjuvant chemotherapy followed by pelvic lymphadenectomy and radical trachelectomy in bulky stage IB1 cervical cancer: a case report

1 reference

12 December 2020

Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer

1 reference

12 December 2020

Retinoic acid and interferon in human cancer: mechanistic and clinical studies.

1 reference

12 December 2020

A phase II multicenter trial of concurrent chemoradiotherapy with weekly nedaplatin in advanced uterine cervical carcinoma: Tohoku Gynecologic Cancer Unit Study

1 reference

12 December 2020

Phase II study of 13-cis-retinoic acid plus interferon-alpha 2a in heavily pretreated squamous carcinoma of the cervix

1 reference

12 December 2020

In vitro radiosensitization by oxaliplatin and 5-fluorouracil in a human colon cancer cell line

1 reference

12 December 2020

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials

1 reference

12 December 2020

Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.

1 reference

12 December 2020

Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer

1 reference

12 December 2020

Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

1 reference

12 December 2020

Concurrent radiation therapy and irinotecan in stage IIIB cervical cancer.

1 reference

12 December 2020

Topoisomerase I gene expression and cell sensitivity to camptothecin in human cell lines of different tumor types.

1 reference

12 December 2020

Gemcitabine activity in cervical cancer cell lines

1 reference

12 December 2020

X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capecitabine (Xeloda) in human cancer xenografts

1 reference

12 December 2020

Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials

1 reference

12 December 2020

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.

1 reference

12 December 2020

Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells

1 reference

12 December 2020

Phase I study of topotecan and radiation therapy in advanced cervical cancer

1 reference

12 December 2020

Phase I trial of concomitant vinorelbine, paclitaxel, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignancies

1 reference

12 December 2020

Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity

1 reference

12 December 2020

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer

1 reference

12 December 2020

Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer

1 reference

12 December 2020

Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines

1 reference

12 December 2020

DT-diaphorase: a target for new anticancer drugs

1 reference

12 December 2020

Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study

1 reference

12 December 2020

Vascular endothelial growth factor in cervical carcinoma

1 reference

12 December 2020

Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri

1 reference

12 December 2020

Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report

1 reference

12 December 2020

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996

1 reference

12 December 2020

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study

1 reference

12 December 2020

Randomized multicenter phase II trial of cisplatin and ifosfamide with or without paclitaxel in recurrent or metastatic carcinoma of the uterine cervix: a Hellenic Cooperative Oncology Group (HeCOG) study.

1 reference

12 December 2020

Phase I trial of erlotinib combined with cisplatin and radiotherapy for patients with locally advanced cervical squamous cell cancer

1 reference

12 December 2020

Phase II study of cisplatin and vinorelbine in squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

Mechanism of the radiosensitization induced by vinorelbine in human non-small cell lung cancer cells

1 reference

12 December 2020

Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer

1 reference

12 December 2020

Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

1 reference

12 December 2020

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

12 December 2020

The effect of paclitaxel on the radiosensitivity of gynecological tumor cells

1 reference

12 December 2020

Paclitaxel: a radiation sensitizer of human cervical cancer cells

1 reference

12 December 2020

4-epidoxorubicin in recurrent cervical cancer

1 reference

12 December 2020

Paclitaxel and carboplatin for recurrent or persistent cancer of the cervix

1 reference

12 December 2020

A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma

1 reference

12 December 2020

Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trials

1 reference

12 December 2020

Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study

1 reference

12 December 2020

Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies

1 reference

12 December 2020

Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer

1 reference

12 December 2020

Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies

1 reference

12 December 2020

A randomized comparison of a rapid versus prolonged (24 hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: a Gynecologic Oncology Group study

1 reference

12 December 2020

A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous c

1 reference

12 December 2020

Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix

1 reference

12 December 2020

Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix

1 reference

12 December 2020

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

1 reference

12 December 2020

Concurrent radiation, mitomycin C and 5-fluorouracil in poor prognosis carcinoma of cervix: preliminary results of a phase I-II study

1 reference

12 December 2020

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

Combined modality therapy of gemcitabine and radiation

1 reference

12 December 2020

Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer

1 reference

12 December 2020

13-cis-Retinoic Acid Plus Interferon -2a: Highly Active Systemic Theraphy for Squamous Cell Carcinoma of the Cervix

1 reference

12 December 2020

Combination effects of irradiation and irinotecan on cervical squamous cell carcinoma cells in vitro

1 reference

12 December 2020

Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.

1 reference

12 December 2020

Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma

1 reference

12 December 2020

A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer

1 reference

12 December 2020

Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix

1 reference

12 December 2020

Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.

1 reference

12 December 2020

Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells

1 reference

12 December 2020

[The intensification of the radiotherapeutic effect on HeLa cells by gemcitabine]

1 reference

12 December 2020

Production of DNA Double-Strand Breaks by Interactions between Carboplatin and Radiation: A Potential Mechanism for Radiopotentiation

1 reference

12 December 2020

10.2165/11534370-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

22 August 2017

1025054684

0 references

1 reference